Joshua Allen
Chief Tech/Sci/R&D Officer at CHIMERIX, INC.
Joshua Allen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHIMERIX, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 | - |
Career history of Joshua Allen
Former positions of Joshua Allen
| Companies | Position | Start | End |
|---|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 2014-08-31 | 2020-12-31 |
Training of Joshua Allen
| University of Pennsylvania | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Joshua Allen
- Experience
